MA27745A1 - Derives d'acide benzoylureidopyridyl-piperidine et pyrrolidinecarboxylique substitues, methode de production de ceux-ci et utilisation de ceux-ci. - Google Patents
Derives d'acide benzoylureidopyridyl-piperidine et pyrrolidinecarboxylique substitues, methode de production de ceux-ci et utilisation de ceux-ci.Info
- Publication number
- MA27745A1 MA27745A1 MA28485A MA28485A MA27745A1 MA 27745 A1 MA27745 A1 MA 27745A1 MA 28485 A MA28485 A MA 28485A MA 28485 A MA28485 A MA 28485A MA 27745 A1 MA27745 A1 MA 27745A1
- Authority
- MA
- Morocco
- Prior art keywords
- benzoylureidopyridyl
- piperidine
- substituted
- acid derivatives
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention se rapporte à des composés de formule (I) dans laquelle les groupes ont la signification indiquée dans la description, ainsi qu'à leurs sels physiologiquement acceptables. Ces composés peuvent par exemple servir de médicaments pour prévenir et traiter un diabète de type 2.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10309929A DE10309929B4 (de) | 2003-03-07 | 2003-03-07 | Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27745A1 true MA27745A1 (fr) | 2006-02-01 |
Family
ID=32945839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA28485A MA27745A1 (fr) | 2003-03-07 | 2005-09-07 | Derives d'acide benzoylureidopyridyl-piperidine et pyrrolidinecarboxylique substitues, methode de production de ceux-ci et utilisation de ceux-ci. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1603895B1 (fr) |
JP (1) | JP2006519795A (fr) |
KR (1) | KR20050108487A (fr) |
CN (1) | CN1759109A (fr) |
AT (1) | ATE386735T1 (fr) |
AU (1) | AU2004218267A1 (fr) |
BR (1) | BRPI0408148A (fr) |
CA (1) | CA2518322A1 (fr) |
CO (1) | CO5690587A2 (fr) |
DE (2) | DE10309929B4 (fr) |
HR (1) | HRP20050779A2 (fr) |
MA (1) | MA27745A1 (fr) |
MX (1) | MXPA05009122A (fr) |
NO (1) | NO20054418L (fr) |
PL (1) | PL377293A1 (fr) |
RU (1) | RU2005131011A (fr) |
WO (1) | WO2004078743A1 (fr) |
ZA (1) | ZA200506119B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7226942B2 (en) | 2004-11-15 | 2007-06-05 | Bristol-Myers Squibb Company | 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
US7365061B2 (en) | 2004-11-15 | 2008-04-29 | Bristol-Myers Squibb Company | 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
WO2006053274A2 (fr) | 2004-11-15 | 2006-05-18 | Bristol-Myers Squibb Company | Derives de tetraline 2-amino-1-fonctionnalises et inhibiteurs correspondants de glycogene phosphorylase |
WO2006055435A1 (fr) | 2004-11-15 | 2006-05-26 | Bristol-Myers Squibb Company | Derives de 2-aminonaphtalene et inhibiteurs de la glycogene phosphorylase associes |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
EP2486005B1 (fr) * | 2009-10-06 | 2014-06-18 | Bristol-Myers Squibb Company | Modulateurs du gpr40 à base de pyrrolidine |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3034004A1 (de) * | 1980-09-10 | 1982-04-22 | Hoechst Ag, 6000 Frankfurt | Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
YU91002A (sh) * | 2000-06-09 | 2006-05-25 | Aventis Pharma Deutschland | Derivati acilfenil-karbamida, postupak za njihovu proizvodnju i njihova primena kao leka |
DE10116768A1 (de) * | 2001-04-04 | 2002-10-10 | Aventis Pharma Gmbh | Acylphenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
PE20021091A1 (es) * | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
DE10125567B4 (de) * | 2001-05-25 | 2004-08-26 | Aventis Pharma Deutschland Gmbh | Carbonamid substituierte Phenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE10215907A1 (de) * | 2002-04-11 | 2003-11-06 | Aventis Pharma Gmbh | Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung |
JP4374428B2 (ja) * | 2002-07-11 | 2009-12-02 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 尿素置換されたおよびウレタン置換されたアシル尿素、それらの製造方法および医薬としてのそれらの使用方法 |
PL373329A1 (en) * | 2002-07-12 | 2005-08-22 | Sanofi-Aventis Deutschland Gmbh | Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
-
2003
- 2003-03-07 DE DE10309929A patent/DE10309929B4/de not_active Expired - Fee Related
-
2004
- 2004-02-21 CA CA002518322A patent/CA2518322A1/fr not_active Abandoned
- 2004-02-21 WO PCT/EP2004/001735 patent/WO2004078743A1/fr active IP Right Grant
- 2004-02-21 RU RU2005131011/04A patent/RU2005131011A/ru not_active Application Discontinuation
- 2004-02-21 JP JP2006504448A patent/JP2006519795A/ja not_active Ceased
- 2004-02-21 DE DE502004006253T patent/DE502004006253D1/de not_active Expired - Lifetime
- 2004-02-21 KR KR1020057016583A patent/KR20050108487A/ko not_active Application Discontinuation
- 2004-02-21 EP EP04713467A patent/EP1603895B1/fr not_active Expired - Lifetime
- 2004-02-21 BR BRPI0408148-0A patent/BRPI0408148A/pt not_active IP Right Cessation
- 2004-02-21 AT AT04713467T patent/ATE386735T1/de not_active IP Right Cessation
- 2004-02-21 CN CNA2004800062407A patent/CN1759109A/zh active Pending
- 2004-02-21 AU AU2004218267A patent/AU2004218267A1/en not_active Abandoned
- 2004-02-21 PL PL377293A patent/PL377293A1/pl not_active Application Discontinuation
- 2004-02-21 MX MXPA05009122A patent/MXPA05009122A/es unknown
-
2005
- 2005-08-01 ZA ZA200506119A patent/ZA200506119B/en unknown
- 2005-09-06 HR HR20050779A patent/HRP20050779A2/xx not_active Application Discontinuation
- 2005-09-06 CO CO05089471A patent/CO5690587A2/es not_active Application Discontinuation
- 2005-09-07 MA MA28485A patent/MA27745A1/fr unknown
- 2005-09-23 NO NO20054418A patent/NO20054418L/no unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20050779A2 (en) | 2006-10-31 |
KR20050108487A (ko) | 2005-11-16 |
EP1603895B1 (fr) | 2008-02-20 |
RU2005131011A (ru) | 2006-05-10 |
DE502004006253D1 (de) | 2008-04-03 |
EP1603895A1 (fr) | 2005-12-14 |
MXPA05009122A (es) | 2005-10-20 |
CO5690587A2 (es) | 2006-10-31 |
ZA200506119B (en) | 2006-11-29 |
BRPI0408148A (pt) | 2006-03-01 |
NO20054418L (no) | 2005-09-23 |
DE10309929B4 (de) | 2006-02-23 |
CN1759109A (zh) | 2006-04-12 |
JP2006519795A (ja) | 2006-08-31 |
DE10309929A1 (de) | 2004-12-02 |
AU2004218267A1 (en) | 2004-09-16 |
PL377293A1 (pl) | 2006-01-23 |
WO2004078743A1 (fr) | 2004-09-16 |
ATE386735T1 (de) | 2008-03-15 |
CA2518322A1 (fr) | 2004-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS20050019A (en) | Heterocyclically substituted benzoylureas,method for their production and their use as medicaments | |
IL176914A0 (en) | Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
NO20050134L (no) | Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse | |
YU70901A (sh) | Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena | |
TNSN06409A1 (en) | Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof | |
MXPA02011458A (es) | Derivados de acilfenilurea, metodos para su produccion y uso de los mismos como farmacos. | |
BG108318A (en) | Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments | |
SE0102299D0 (sv) | Compounds | |
SE0102300D0 (sv) | Compounds | |
HRP20050870A2 (en) | Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter | |
MA28340A1 (fr) | Derives de l'acide 7- amino-4- quinolone-3-carboxylique substitues par un groupe cycloalkyle, methode pour leur production et leur utilisation en tant que medicaments | |
TW200510333A (en) | Benzimidazole compounds | |
MA27745A1 (fr) | Derives d'acide benzoylureidopyridyl-piperidine et pyrrolidinecarboxylique substitues, methode de production de ceux-ci et utilisation de ceux-ci. | |
MA27232A1 (fr) | Derives d'acide n-benzoylureidocinnamique, leurs procedes de preparation et leurs utilisations | |
MA27649A1 (fr) | Derives d'acylphenyluree substitues par carbonylamino, methode de production et d'utilisation de ceux-ci. | |
TNSN06233A1 (en) | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments | |
ATE424195T1 (de) | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen | |
BR0312586A (pt) | Derivados de pirolidina como antagonistas e oxitocina | |
MXPA05008331A (es) | Derivados de 3-(benzoilureido)-tiofeno sustituido, metodo para su produccion y uso de los mismos. | |
ATE369849T1 (de) | Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen | |
DE60209122D1 (de) | Bernsteinsäurederivate | |
TNSN05008A1 (en) | Heterocyclically substituted benzoylureas, method for their production and their use as medicaments. | |
DE50310168D1 (de) | Polyisoprenyl-benzophenon-derivate, verfahren zu ihrer herstellung und verwendung derselben |